The COVID Informatics Center @MountSinaiNYC is utilizing #artificialintelligence software from @Clinithink to determine key findings in #COVID19 patient data, in an effort to improve #treatment methods: hubs.ly/H0zBz6k0 @girish_nadkarni #medicalresearchanalysis #AI

Using Clinithink’s platform “CLiXTM unlock,” the COVID Informatics Center (@MountSinaiNYC) aim to find patterns that can ultimately lead to new discoveries in COVID-19 treatment hubs.ly/H0zBGVJ0 #medicalresearchanalysis #AIresearch #clinithink #AIsolutions

The world-leading New York hospital, @MountSinaiNYC, has extended its collaboration with London-based software company @clinithink as part of its extensive COVID19 research. hubs.ly/H0zBysz0 #COVID19 #medicalresearchanalysis #clinithink

We are thrilled to “extend collab with @mountsinainyc to determine key findings in COVID19 data hubs.ly/H0zBdTf0 #beatCOVID19 #NLP #AIhealthcare #virusresearch

Find our more about how @clinithink extends collab with @mountsinainyc to determine key findings in COVID19 data @MountSinaiNYC using our technology to reveal new insights into COVID-19. hubs.ly/H0zCT1l0 #beatCOVID19 #NLP #AIhealthcare #smarthealthcar

Thank you @eHealthDC for an interesting and informative webinar yesterday.

Exciting news from Alexion - For about two months, our partners there have been exploring whether Soliris might hold promise as a treatment for severe COVID-19, and yesterday they confirmed they are starting a phase 3 trial of Ultomiris for Covid treatment too. Good luck Alexion.

Thank you to KLAS for including us in their COVID-19 Technology & Services Solutions Guide and recognising that the world needs advanced tech-enabled solutions in order to successfully fight today's pandemic. #KLASresearch #Technology #AI #BetterTogether

AstraZeneca have revealed plans to launch a global clinical trial to look at using Calquence (currently used to treat blood cancers) to reduce the respiratory harm caused by coronavirus. This could potentially cut deaths & reduce the need for ventilation in patients. Go well AZ.

Doctors, nurses, carers and healthcare providers are talking. They want us to know what they are faced with, so they are using social media and digital communication channels in greater numbers than ever before. Let's listen. Let’s drive change.

Is the pandemic a time for the clinical research community to reflect? Or is it actually providing us with a crucial inflection point? Sarah Beeby poses the question for Applied Clinical Trials online appliedclinicaltrialsonline.…

Whilst recruitment for clinical trials is inevitably slowing down, we are still working with the CLiX community to provide vital patient data insights to biopharma customers. Let’s keep working together to identify those at risk and focus resources on where they are most needed

At Clinithink we work hand in hand with an amazing industry - No fewer than 50 Coronavirus vaccines are in early development across the biopharma landscape, and researchers are exploring about 10 different approaches to mass scale up. We can do this!

The Head of the coronavirus program at the National Institute of Allergy and Infectious Diseases’ Vaccine Research Center has said the team’s mRNA project (in partnership with Moderna) entered the clinic just 66 DAYS after they received COVID-19s viral sequence. Surely a record?

Research records are being broken in the name of Coronavirus. We should all be very proud of the industry we work in.

Coronavirus shots will undergo a faster-than-expected clinical trial on volunteers in the Seattle area wsj.com/articles/recruitment… via @WSJ